HereToday said, Quote: For quick numbers on Bril
Post# of 72440
(Total Views: 421)
Posted On: 02/09/2021 12:41:00 AM
HereToday said,
Quote: For quick numbers on Brilacidin for Covid-19 only - $400 million Upfront payment with a 20% Gross Sales Royalty payment.
20%? Absolutely not! If Brilacidin works against Covid, the governments of the world are going to write very large checks THIS YEAR. A big upfront payment is not worth much when the gross is going to dwarf the upfront payment in the short term. And giving 80% of the revenue to a “partner” who did NOTHING to get us to this point is an insult. Again, if Brilacidin works, we do NOT need a BP “partner”. We already contract the production and the finished product can be direct shipped to the appropriate address. All that remains is to deposit the checks (or just confirm that the proper funding was wired into our account).
After the Covid crisis has passed, I could see Leo signing with a BP to develop Brilacidin for innumerable diseases (bacterial, virus, parasitic, IBD, and perhaps even fungal or other conditions). But hopefully Leo is smart enough to negotiate a sliding scale of royalties that gets us to 50% after the gross reaches a billion or two.
Quote: For quick numbers on Brilacidin for Covid-19 only - $400 million Upfront payment with a 20% Gross Sales Royalty payment.
20%? Absolutely not! If Brilacidin works against Covid, the governments of the world are going to write very large checks THIS YEAR. A big upfront payment is not worth much when the gross is going to dwarf the upfront payment in the short term. And giving 80% of the revenue to a “partner” who did NOTHING to get us to this point is an insult. Again, if Brilacidin works, we do NOT need a BP “partner”. We already contract the production and the finished product can be direct shipped to the appropriate address. All that remains is to deposit the checks (or just confirm that the proper funding was wired into our account).
After the Covid crisis has passed, I could see Leo signing with a BP to develop Brilacidin for innumerable diseases (bacterial, virus, parasitic, IBD, and perhaps even fungal or other conditions). But hopefully Leo is smart enough to negotiate a sliding scale of royalties that gets us to 50% after the gross reaches a billion or two.
(2)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼